Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FQ2GV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,253
Award facts
- Contract value 100% obligated
- $28,253.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,253.21 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml pen injectors on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic treatment used for conditions including atopic dermatitis, asthma, and eosinophilic disorders, representing a critical pharmaceutical supply for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems. The company's consistent receipt of competitively awarded, firm fixed-price delivery orders demonstrates its established capability and qualification to fulfill federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FQ2GV?
SPE2DB25FQ2GV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FQ2GV worth?
The government has obligated $28,253 on SPE2DB25FQ2GV.
Is contract SPE2DB25FQ2GV an order under another contract?
Yes. SPE2DB25FQ2GV is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2GV competed?
The extent of competition for SPE2DB25FQ2GV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award